The Spectrum of Epidemiology Underlying Sudden Cardiac Death

Circulation Research

Volumn 116, Issue 12, 2015, Pages 1887-1906

  Hayashi, Meiso ^a   Shimizu, Wataru ^a   Albert, Christine M ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cardiomyopathies; coronary disease; death, sudden, cardiac; epidemiology

Indexed keywords

ALCOHOL;

AIR POLLUTION; ALCOHOL CONSUMPTION; ARTICLE; ATRIAL FIBRILLATION; AUTOPSY; BRUGADA SYNDROME; CARDIAC PATIENT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONGESTIVE CARDIOMYOPATHY; DEMOGRAPHY; DIET; DISEASE PREDISPOSITION; FAMILY HISTORY; HEART REPOLARIZATION; HEART RHYTHM; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LONG QT SYNDROME; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEASONAL VARIATION; SOCIAL PSYCHOLOGY; SUDDEN CARDIAC DEATH; SURVIVAL; VALVULAR HEART DISEASE; AGE DISTRIBUTION; ARRHYTHMIAS, CARDIAC; COMORBIDITY; COMPLICATION; DEATH, SUDDEN, CARDIAC; ENVIRONMENT; ETHNIC GROUP; FEMALE; GENETICS; HABIT; HEART DISEASES; HEART MUSCLE CONDUCTION SYSTEM; MALE; PSYCHOLOGY; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; ARRHYTHMIAS, CARDIAC; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ENVIRONMENT; ETHNIC GROUPS; FEMALE; HABITS; HEART CONDUCTION SYSTEM; HEART DISEASES; HUMANS; INCIDENCE; MALE; PSYCHOLOGY; RISK FACTORS; SEX DISTRIBUTION;

EID: 84938927110     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304521     Document Type: Article

References (269)

1. Lopshire JC, Zipes DP. Sudden cardiac death: better understanding of risks, mechanisms, and treatment. Circulation. 2006;114:1134-1136. doi: 10.1161/CIRCULATIONAHA.106.647933.
2. Fishman GI, Chugh SS, Dimarco JP, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335-2348. doi: 10.1161/CIRCULATIONAHA.110.976092.
3. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457-464.
4. Weisfeldt ML, Everson-Stewart S, Sitlani C, Rea T, Aufderheide TP, Atkins DL, Bigham B, Brooks SC, Foerster C, Gray R, Ornato JP, Powell J, Kudenchuk PJ, Morrison LJ; Resuscitation Outcomes Consortium Investigators. Ventricular tachyarrhythmias after cardiac arrest in public versus at home. N Engl J Med. 2011;364:313-321. doi: 10.1056/NEJMoa1010663.
5. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, Stampfer MJ, Manson JE. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107:2096-2101. doi: 10.1161/01.CIR.0000065223.21530.11.
6. Gillum RF. Geographic variation in sudden coronary death. Am Heart J. 1990;119:380-389.
7. Myerburg RJ, Castellanos A. Sudden cardiac death. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: From cell to bedside. 5th edn. Philadelphia, PA: Saunders Elsevier; 2009:797-808.
8. Niemeijer MN, van den Berg ME, Leening MJG, Hofman A, Franco OH, Deckers JW, Heeringa J, Rijnbeek PR, Stricker BH, Eijgelsheim M. Declining incidence of sudden cardiac death from 1990-2010 in a general middle-aged and elderly population: The rotterdam study. Heart Rhythm. 2015;12:123-129.
9. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation. 2004;110:522-527. doi: 10.1161/01.CIR.0000136993.34344.41.
10. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163.
11. Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation. 2011;123:46-52. doi: 10.1161/CIRCULATIONAHA.110.964999.
12. Gerber Y, Jacobsen SJ, Frye RL, Weston SA, Killian JM, Roger VL. Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation. 2006;113:2285-2292. doi: 10.1161/ CIRCULATIONAHA.105.590463.
13. Cupples LA, Gagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death. Circulation. 1992;85:I11-I18.
14. Gorgels AP, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJ. Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J. 2003;24:1204-1209.
15. Kong MH, Fonarow GC, Peterson ED, Curtis AB, Hernandez AF, Sanders GD, Thomas KL, Hayes DL, Al-Khatib SM. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol. 2011;57:794-801. doi: 10.1016/j.jacc.2010.09.064.
16. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125:1043-1052. doi: 10.1161/ CIRCULATIONAHA.111.023846.
17. Berdowski J, Berg RA, Tijssen JG, Koster RW. Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation. 2010;81:1479-1487. doi: 10.1016/j. resuscitation.2010.08.006.
18. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol. 2004;44:1268-1275. doi: 10.1016/j.jacc.2004.06.029.
19. Zipes DP, Camm AJ, Borggrefe M, et al; American College of Cardiology/ American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385-e484. doi: 10.1161/ CIRCULATIONAHA.106.178233.
20. de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van Ree JW, Daemen MJ, Houben LG, Wellens HJ. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol. 1997;30:1500-1505.
21. Byrne R, Constant O, Smyth Y, Callagy G, Nash P, Daly K, Crowley J. Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. Eur Heart J. 2008;29:1418-1423. doi: 10.1093/eurheartj/ehn155.
22. Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS, Zhou HL, Gou ZP, Zhao LC, Niu HX, Chen KP, Mai JZ, Chu LN, Zhang S. Incidence of sudden cardiac death in China: analysis of 4 regional populations. J Am Coll Cardiol. 2009;54:1110-1118. doi: 10.1016/j.jacc.2009.06.016.
23. Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL, Bundgaard H, Svendsen JH, Haunsø S, Tfelt-Hansen J. Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J. 2011;32:983-990. doi: 10.1093/eurheartj/ehq428.
24. Margey R, Roy A, Tobin S, O'Keane CJ, McGorrian C, Morris V, Jennings S, Galvin J. Sudden cardiac death in 14- to 35-year olds in Ireland from 2005 to 2007: a retrospective registry. Europace. 2011;13:1411-1418. doi: 10.1093/europace/eur161.
25. Papadakis M, Sharma S, Cox S, Sheppard MN, Panoulas VF, Behr ER. The magnitude of sudden cardiac death in the young: a death certificatebased review in England and Wales. Europace. 2009;11:1353-1358. doi: 10.1093/europace/eup229.
26. Shojania KG, Burton EC. The vanishing nonforensic autopsy. N Engl J Med. 2008;358:873-875. doi: 10.1056/NEJMp0707996.
27. Lunetta P, Lounamaa A, Sihvonen S. Surveillance of injury-related deaths: medicolegal autopsy rates and trends in Finland. Inj Prev. 2007;13:282-284. doi: 10.1136/ip.2006.012922.
28. Field JM, Hazinski MF, Sayre MR, et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:S640-S656. doi: 10.1161/CIRCULATIONAHA.110.970889.
29. Chan PS, McNally B, Tang F, Kellermann A; CARES Surveillance Group. Recent trends in survival from out-of-hospital cardiac arrest in the United States. Circulation. 2014;130:1876-1882. doi: 10.1161/ CIRCULATIONAHA.114.009711.
30. Wissenberg M, Lippert FK, Folke F, et al. Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest. JAMA. 2013;310:1377-1384. doi: 10.1001/jama.2013.278483.
31. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA. 2002;288:3008-3013.
32. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I; Resuscitation Outcomes Consortium Investigators. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008;300:1423-1431. doi: 10.1001/jama.300.12.1423.
33. Myerburg RJ, Halperin H, Egan DA, et al. Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2013;128:2532-2541. doi: 10.1161/ CIRCULATIONAHA.113.004490.
34. Straus SM, Bleumink GS, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC. The incidence of sudden cardiac death in the general population. J Clin Epidemiol. 2004;57:98-102. doi: 10.1016/ S0895-4356(03)00210-5.
35. Kuisma M, Repo J, Alaspää A. The incidence of out-of-hospital ventricular fibrillation in Helsinki, Finland, from 1994 to 1999. Lancet. 2001;358:473-474. doi: 10.1016/S0140-6736(01)05634-3.
36. Krahn AD, Connolly SJ, Roberts RS, Gent M; ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004;147:837-840. doi: 10.1016/j.ahj.2003.12.017.
37. Iwami T, Hiraide A, Nakanishi N, Hayashi Y, Nishiuchi T, Yukioka H, Yoshiya I, Sugimoto H. Age and sex analyses of out-of-hospital cardiac arrest in Osaka, Japan. Resuscitation. 2003;57:145-152.
38. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136:205-212. doi: 10.1053/hj.1998. v136.90226.
39. Rho RW, Patton KK, Poole JE, Cleland JG, Shadman R, Anand I, Maggioni AP, Carson PE, Swedberg K, Levy WC. Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation. 2012;126:2402-2407. doi: 10.1161/CIRCULATIONAHA.111.069245.
40. Wissenberg M, Hansen CM, Folke F, Lippert FK, Weeke P, Karlsson L, Rajan S, Søndergaard KB, Kragholm K, Christensen EF, Nielsen SL, Køber L, Gislason GH, Torp-Pedersen C. Survival after out-of-hospital cardiac arrest in relation to sex: a nationwide registry-based study. Resuscitation. 2014;85:1212-1218. doi: 10.1016/j.resuscitation.2014.06.008.
41. Akahane M, Ogawa T, Koike S, Tanabe S, Horiguchi H, Mizoguchi T, Yasunaga H, Imamura T. The effects of sex on out-of-hospital cardiac arrest outcomes. Am J Med. 2011;124:325-333. doi: 10.1016/j. amjmed.2010.10.020.
42. Becker LB, Han BH, Meyer PM, Wright FA, Rhodes KV, Smith DW, Barrett J. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. N Engl J Med. 1993;329:600-606. doi: 10.1056/NEJM199308263290902.
43. Cowie MR, Fahrenbruch CE, Cobb LA, Hallstrom AP. Out-of-hospital cardiac arrest: racial differences in outcome in Seattle. Am J Public Health. 1993;83:955-959.
44. Bertoia ML, Allison MA, Manson JE, Freiberg MS, Kuller LH, Solomon AJ, Limacher MC, Johnson KC, Curb JD, Wassertheil-Smoller S, Eaton CB. Risk factors for sudden cardiac death in post-menopausal women. J Am Coll Cardiol. 2012;60:2674-2682. doi: 10.1016/j.jacc.2012.09.031.
45. Okin PM, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB. Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study. Heart Rhythm. 2012;9:531-537. doi: 10.1016/j.hrthm.2011.11.008.
46. Shah KS, Shah AS, Bhopal R. Systematic review and meta-analysis of out-of-hospital cardiac arrest and race or ethnicity: black US populations fare worse. Eur J Prev Cardiol. 2014;21:619-638. doi: 10.1177/2047487312451815.
47. Teodorescu C, Reinier K, Dervan C, Uy-Evanado A, Samara M, Mariani R, Gunson K, Jui J, Chugh SS. Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. Circulation. 2010;122:2116-2122. doi: 10.1161/ CIRCULATIONAHA.110.966333.
48. Chan PS, Nichol G, Krumholz HM, Spertus JA, Jones PG, Peterson ED, Rathore SS, Nallamothu BK; American Heart Association National Registry of Cardiopulmonary Resuscitation (NRCPR) Investigators. Racial differences in survival after in-hospital cardiac arrest. JAMA. 2009;302:1195-1201. doi: 10.1001/jama.2009.1340.
49. Sasson C, Magid DJ, Chan P, Root ED, McNally BF, Kellermann AL, Haukoos JS; CARES Surveillance Group. Association of neighborhood characteristics with bystander-initiated CPR. N Engl J Med. 2012;367:1607-1615. doi: 10.1056/NEJMoa1110700.
50. Willey JZ, Rodriguez CJ, Moon YP, Paik MC, Di Tullio MR, Homma S, Sacco RL, Elkind MS. Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox. Ann Epidemiol. 2012;22:303-309. doi: 10.1016/j. annepidem.2012.02.014.
51. Gillum RF. Sudden cardiac death in Hispanic Americans and African Americans. Am J Public Health. 1997;87:1461-1466.
52. Steinhaus DA, Vittinghoff E, Moffatt E, Hart AP, Ursell P, Tseng ZH. Characteristics of sudden arrhythmic death in a diverse, urban community. Am Heart J. 2012;163:125-131. doi: 10.1016/j.ahj.2011.09.016.
53. Maruyama M, Ohira T, Imano H, Kitamura A, Kiyama M, Okada T, Maeda K, Yamagishi K, Noda H, Ishikawa Y, Shimamoto T, Iso H. Trends in sudden cardiac death and its risk factors in Japan from 1981 to 2005: The circulatory risk in communities study (circs). BMJ open. 2012;2:e000573.
54. SPAIN DM, BRADESS VA, MOHR C. Coronary atherosclerosis as a cause of unexpected and unexplained death. An autopsy study from 1949- 1959. JAMA. 1960;174:384-388.
55. Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation. 1996;93:1170-1176.
56. Burke AP, Farb A, Pestaner J, Malcom GT, Zieske A, Kutys R, Smialek J, Virmani R. Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks. Circulation. 2002;105:419-424.
57. Nagata M, Ninomiya T, Doi Y, Hata J, Ikeda F, Mukai N, Tsuruya K, Oda Y, Kitazono T, Kiyohara Y. Temporal trends in sudden unexpected death in a general population: the Hisayama study. Am Heart J. 2013;165:932- 938.e1. doi: 10.1016/j.ahj.2013.02.028.
58. Priori SG, Borggrefe M, Camm AJ, Hauer RN, Klein H, Kuck KH, Schwartz PJ, Touboul P, Wellens HJ. Unexplained cardiac arrest. The need for a prospective registry. Eur Heart J. 1992;13:1445-1446.
59. Chugh SS, Chung K, Zheng ZJ, John B, Titus JL. Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women. Am Heart J. 2003;146:635-639. doi: 10.1016/ S0002-8703(03)00323-5.
60. Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J. 2013;77:2419-2431.
61. Kaltman JR, Thompson PD, Lantos J, et al. Screening for sudden cardiac death in the young: report from a national heart, lung, and blood institute working group. Circulation. 2011;123:1911-1918. doi: 10.1161/ CIRCULATIONAHA.110.017228.
62. Greene HL. Sudden arrhythmic cardiac death-mechanisms, resuscitation and classification: the Seattle perspective. Am J Cardiol. 1990;65:4B-12B.
63. Eisenberg MS, Copass MK, Hallstrom AP, Blake B, Bergner L, Short FA, Cobb LA. Treatment of out-of-hospital cardiac arrests with rapid defibrillation by emergency medical technicians. N Engl J Med. 1980;302:1379-1383. doi: 10.1056/NEJM198006193022502.
64. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99:1978-1983.
65. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995;91:1749-1756.
66. Kucharska-Newton AM, Couper DJ, Pankow JS, Prineas RJ, Rea TD, Sotoodehnia N, Chakravarti A, Folsom AR, Siscovick DS, Rosamond WD. Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study. Acta Diabetol. 2010;47(Suppl 1):161-168. doi: 10.1007/s00592-009-0157-9.
67. Junttila MJ, Barthel P, Myerburg RJ, Mäkikallio TH, Bauer A, Ulm K, Kiviniemi A, Tulppo M, Perkiömäki JS, Schmidt G, Huikuri HV. Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm. 2010;7:1396-1403. doi: 10.1016/j.hrthm.2010.07.031.
68. Deo R, Vittinghoff E, Lin F, Tseng ZH, Hulley SB, Shlipak MG. Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. Arch Intern Med. 2011;171:1703-1709. doi: 10.1001/ archinternmed.2011.328.
69. Mayet J, Shahi M, Foale RA, Poulter NR, Sever PS, McG Thom SA. Racial differences in cardiac structure and function in essential hypertension. BMJ. 1994;308:1011-1014.
70. Vlietstra RE, Kronmal RA, Oberman A, Frye RL, Killip T 3rd. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA. 1986;255:1023-1027.
71. Goldenberg I, Jonas M, Tenenbaum A, Boyko V, Matetzky S, Shotan A, Behar S, Reicher-Reiss H; Bezafibrate Infarction Prevention Study Group. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med. 2003;163:2301-2305. doi: 10.1001/archinte.163.19.2301.
72. Sandhu RK, Jimenez MC, Chiuve SE, Fitzgerald KC, Kenfield SA, Tedrow UB, Albert CM. Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ Arrhythm Electrophysiol. 2012;5:1091-1097. doi: 10.1161/CIRCEP.112.975219.
73. Rahimi K, Majoni W, Merhi A, Emberson J. Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials. Eur Heart J. 2012;33:1571-1581. doi: 10.1093/eurheartj/ehs005.
74. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, Arbogast P, Raghunathan TE, Cobb LA. Family history as a risk factor for primary cardiac arrest. Circulation. 1998;97:155-160.
75. Dekker LR, Bezzina CR, Henriques JP, Tanck MW, Koch KT, Alings MW, Arnold AE, de Boer MJ, Gorgels AP, Michels HR, Verkerk A, Verheugt FW, Zijlstra F, Wilde AA. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation. 2006;114:1140-1145. doi: 10.1161/ CIRCULATIONAHA.105.606145.
76. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation. 2006;114:1462-1467. doi: 10.1161/ CIRCULATIONAHA.106.624593.
77. Jabbari R, Engstrom T, Glinge C, et al. Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first STelevation myocardial infarction: A nationwide study in Denmrk. J Am Heart Assoc. 2014. In press.
78. Bezzina CR, Pazoki R, Bardai A, et al. Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat Genet. 2010;42:688-691. doi: 10.1038/ng.623.
79. Arking DE, Junttila MJ, Goyette P, et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet. 2011;7:e1002158. doi: 10.1371/journal.pgen.1002158.
80. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-1367.
81. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23-28.
82. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS; Cardiovascular Health Study. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107:1372-1377.
83. Chiuve SE, Rimm EB, Sandhu RK, Bernstein AM, Rexrode KM, Manson JE, Willett WC, Albert CM. Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr. 2012;96:498-507.
84. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118. doi: 10.1056/ NEJMoa012918.
85. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646-2652. doi: 10.1161/01.CIR.0000069566.78305.33.
86. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: Results of the gissi-prevenzione trial. Gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico. Lancet. 1999;354:447-455.
87. Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015-2026. doi: 10.1056/NEJMoa1003603.
88. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, Gottwik M, Steinbeck G, Del Castillo U, Sack R, Worth H, Katus H, Spitzer W, Sabin G, Senges J; OMEGA Study Group. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122:2152-2159. doi: 10.1161/ CIRCULATIONAHA.110.948562.
89. Chiuve SE, Korngold EC, Januzzi JL Jr, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93:253-260. doi: 10.3945/ajcn.110.002253.
90. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010;160:464-470. doi: 10.1016/j.ahj.2010.06.012.
91. Zarraga IG, Schwarz ER. Impact of dietary patterns and interventions on cardiovascular health. Circulation. 2006;114:961-973. doi: 10.1161/ CIRCULATIONAHA.105.603910.
92. Chiuve SE, Fung TT, Rexrode KM, Spiegelman D, Manson JE, Stampfer MJ, Albert CM. Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA. 2011;306:62-69. doi: 10.1001/ jama.2011.907.
93. Bertoia ML, Triche EW, Michaud DS, Baylin A, Hogan JW, Neuhouser ML, Tinker LF, Van Horn L, Waring ME, Li W, Shikany JM, Eaton CB. Mediterranean and Dietary Approaches to Stop Hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am J Clin Nutr. 2014;99:344-351. doi: 10.3945/ajcn.112.056135.
94. Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM, Hennekens CH. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation. 1999;100:944-950.
95. Chiuve SE, Rimm EB, Mukamal KJ, Rexrode KM, Stampfer MJ, Manson JE, Albert CM. Light-to-moderate alcohol consumption and risk of sudden cardiac death in women. Heart Rhythm. 2010;7:1374-1380. doi: 10.1016/j.hrthm.2010.05.035.
96. Bertoia ML, Triche EW, Michaud DS, Baylin A, Hogan JW, Neuhouser ML, Freiberg MS, Allison MA, Safford MM, Li W, Mossavar-Rahmani Y, Rosal MC, Eaton CB. Long-term alcohol and caffeine intake and risk of sudden cardiac death in women. Am J Clin Nutr. 2013;97:1356-1363. doi: 10.3945/ ajcn.112.044248.
97. Wannamethee G, Shaper AG. Alcohol and sudden cardiac death. Br Heart J. 1992;68:443-448.
98. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829-1834. doi: 10.1056/NEJM199312163292501.
99. Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S; RELY Investigators. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 2013;128:2192-2201. doi: 10.1161/CIRCULATIONAHA.112.000491.
100. Chen LY, Sotoodehnia N, Bůžková P, Lopez FL, Yee LM, Heckbert SR, Prineas R, Soliman EZ, Adabag S, Konety S, Folsom AR, Siscovick D, Alonso A. Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. JAMA Intern Med. 2013;173:29-35. doi: 10.1001/2013.jamainternmed.744.
101. Bardai A, Blom MT, van Hoeijen DA, van Deutekom HW, Brouwer HJ, Tan HL. Atrial fibrillation is an independent risk factor for ventricular fibrillation: a large-scale population-based case-control study. Circ Arrhythm Electrophysiol. 2014;7:1033-1039. doi: 10.1161/ CIRCEP.114.002094.
102. Reinier K, Marijon E, Uy-Evanado A, Teodorescu C, Narayanan K, Chugh H, Gunson K, Jui J, Chugh SS. The association between atrial fibrillation and sudden cardiac death: the relevance of heart failure. JACC Heart Fail. 2014;2:221-227. doi: 10.1016/j.jchf.2013.12.006.
103. Collins AJ, Foley RN, Chavers B, et al. United states renal data system 2011 annual data report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59:A7, e1-420.
104. Deo R, Sotoodehnia N, Katz R, Sarnak MJ, Fried LF, Chonchol M, Kestenbaum B, Psaty BM, Siscovick DS, Shlipak MG. Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes. 2010;3:159-164. doi: 10.1161/CIRCOUTCOMES.109.875369.
105. Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, Herges RM, Howard DE, Somers VK. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10, 701 adults. J Am Coll Cardiol. 2013;62:610-616. doi: 10.1016/j.jacc.2013.04.080.
106. Bardai A, Blom MT, van Noord C, Verhamme KM, Sturkenboom MC, Tan HL. Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart. 2015;101:17-22. doi: 10.1136/ heartjnl-2014-305664.
107. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Metaanalysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 1997;79:1512-1516.
108. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol. 1992;70:65-68.
109. Peckova M, Fahrenbruch CE, Cobb LA, Hallstrom AP. Weekly and seasonal variation in the incidence of cardiac arrests. Am Heart J. 1999;137:512-515.
110. Arntz HR, Willich SN, Schreiber C, Brüggemann T, Stern R, Schultheiss HP. Diurnal, weekly and seasonal variation of sudden death. Populationbased analysis of 24, 061 consecutive cases. Eur Heart J. 2000;21:315-320. doi: 10.1053/euhj.1999.1739.
111. Peters RW. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience). Am J Cardiol. 1990;66:57G-59G.
112. Gerber Y, Jacobsen SJ, Killian JM, Weston SA, Roger VL. Seasonality and daily weather conditions in relation to myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, 1979 to 2002. J Am Coll Cardiol. 2006;48:287-292. doi: 10.1016/j.jacc.2006.02.065.
113. Chung FP, Li HR, Chong E, Pan CH, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Lin WY, Shaw KP, Chen SA. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy: the effect of meteorological factors. Heart Rhythm. 2013;10:1859-1866. doi: 10.1016/j.hrthm.2013.09.069.
114. Takigawa M, Noda T, Shimizu W, Miyamoto K, Okamura H, Satomi K, Suyama K, Aihara N, Kamakura S, Kurita T. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm. 2008;5:1523-1527. doi: 10.1016/j.hrthm.2008.08.022.
115. Empana JP, Sauval P, Ducimetiere P, Tafflet M, Carli P, Jouven X. Increase in out-of-hospital cardiac arrest attended by the medical mobile intensive care units, but not myocardial infarction, during the 2003 heat wave in Paris, France. Crit Care Med. 2009;37:3079-3084. doi: 10.1097/ CCM.0b013e3181b0868f.
116. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311:874-877. doi: 10.1056/NEJM198410043111402.
117. Lemaitre RN, Siscovick DS, Raghunathan TE, Weinmann S, Arbogast P, Lin DY. Leisure-time physical activity and the risk of primary cardiac arrest. Arch Intern Med. 1999;159:686-690.
118. Multiple Risk Factor Intervention Trial Research Group. Risk factor changes and mortality results. JAMA. 1982;248:1465-1477.
119. Whang W, Manson JE, Hu FB, Chae CU, Rexrode KM, Willett WC, Stampfer MJ, Albert CM. Physical exertion, exercise, and sudden cardiac death in women. JAMA. 2006;295:1399-1403. doi: 10.1001/ jama.295.12.1399.
120. Kannel WB. Exercise and sudden death. JAMA. 1982;248:3143-3144.
121. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000;343:1355-1361. doi: 10.1056/ NEJM200011093431902.
122. Berdowski J, de Beus MF, Blom M, Bardai A, Bots ML, Doevendans PA, Grobbee DE, Tan HL, Tijssen JG, Koster RW, Mosterd A. Exercise-related out-of-hospital cardiac arrest in the general population: incidence and prognosis. Eur Heart J. 2013;34:3616-3623. doi: 10.1093/eurheartj/eht401.
123. Marijon E, Tafflet M, Celermajer DS, Dumas F, Perier MC, Mustafic H, Toussaint JF, Desnos M, Rieu M, Benameur N, Le Heuzey JY, Empana JP, Jouven X. Sports-related sudden death in the general population. Circulation. 2011;124:672-681. doi: 10.1161/CIRCULATIONAHA.110.008979.
124. Kim JH, Malhotra R, Chiampas G, d'Hemecourt P, Troyanos C, Cianca J, Smith RN, Wang TJ, Roberts WO, Thompson PD, Baggish AL; Race Associated Cardiac Arrest Event Registry (RACER) Study Group. Cardiac arrest during long-distance running races. N Engl J Med. 2012;366:130-140. doi: 10.1056/NEJMoa1106468.
125. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89:1992-1997.
126. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation. 2005;111:480-487. doi: 10.1161/01. CIR.0000153813.64165.5D.
127. Empana JP, Jouven X, Lemaitre RN, Sotoodehnia N, Rea T, Raghunathan TE, Simon G, Siscovick DS. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med. 2006;166:195-200. doi: 10.1001/ archinte.166.2.195.
128. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol. 2009;53:950-958. doi: 10.1016/j. jacc.2008.10.060.
129. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry. 2002;63(Suppl 9):5-11.
130. Weeke P, Jensen A, Folke F, et al. Antidepressant use and risk of outof- hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther. 2012;92:72-79. doi: 10.1038/clpt.2011.368.
131. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-235. doi: 10.1056/NEJMoa0806994.
132. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413-419. doi: 10.1056/ NEJM199602153340701.
133. Meisel SR, Kutz I, Dayan KI, Pauzner H, Chetboun I, Arbel Y, David D. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet. 1991;338:660-661.
134. Kitamura T, Kiyohara K, Iwami T. The great east Japan earthquake and out-of-hospital cardiac arrest. N Engl J Med. 2013;369:2165-2167. doi: 10.1056/NEJMc1306058.
135. Niiyama M, Tanaka F, Nakajima S, Itoh T, Matsumoto T, Kawakami M, Naganuma Y, Omama S, Komatsu T, Onoda T, Sakata K, Ichikawa T, Nakamura M. Population-based incidence of sudden cardiac and unexpected death before and after the 2011 earthquake and tsunami in Iwate, northeast Japan. J Am Heart Assoc. 2014;3: e000798. doi: 10.1161/ JAHA.114.000798.
136. Teng TH, Williams TA, Bremner A, Tohira H, Franklin P, Tonkin A, Jacobs I, Finn J. A systematic review of air pollution and incidence of out-of-hospital cardiac arrest. J Epidemiol Community Health. 2014;68:37-43. doi: 10.1136/jech-2013-203116.
137. Forastiere F, Stafoggia M, Picciotto S, Bellander T, D'Ippoliti D, Lanki T, von Klot S, Nyberg F, Paatero P, Peters A, Pekkanen J, Sunyer J, Perucci CA. A case-crossover analysis of out-of-hospital coronary deaths and air pollution in Rome, Italy. Am J Respir Crit Care Med. 2005;172:1549-1555. doi: 10.1164/rccm.200412-1726OC.
138. Raza A, Bellander T, Bero-Bedada G, Dahlquist M, Hollenberg J, Jonsson M, Lind T, Rosenqvist M, Svensson L, Ljungman PL. Short-term effects of air pollution on out-of-hospital cardiac arrest in Stockholm. Eur Heart J. 2014;35:861-868. doi: 10.1093/eurheartj/eht489.
139. Silverman RA, Ito K, Freese J, Kaufman BJ, De Claro D, Braun J, Prezant DJ. Association of ambient fine particles with out-of-hospital cardiac arrests in New York City. Am J Epidemiol. 2010;172:917-923. doi: 10.1093/aje/kwq217.
140. Ensor KB, Raun LH, Persse D. A case-crossover analysis of out-of-hospital cardiac arrest and air pollution. Circulation. 2013;127:1192-1199. doi: 10.1161/CIRCULATIONAHA.113.000027.
141. Dennekamp M, Akram M, Abramson MJ, Tonkin A, Sim MR, Fridman M, Erbas B. Outdoor air pollution as a trigger for out-of-hospital cardiac arrests. Epidemiology. 2010;21:494-500. doi: 10.1097/ EDE.0b013e3181e093db.
142. Levy D, Sheppard L, Checkoway H, Kaufman J, Lumley T, Koenig J, Siscovick D. A case-crossover analysis of particulate matter air pollution and out-of-hospital primary cardiac arrest. Epidemiology. 2001;12:193-199.
143. Wichmann J, Folke F, Torp-Pedersen C, Lippert F, Ketzel M, Ellermann T, Loft S. Out-of-hospital cardiac arrests and outdoor air pollution exposure in Copenhagen, Denmark. PLoS One. 2013;8:e53684. doi: 10.1371/ journal.pone.0053684.
144. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356:447-458. doi: 10.1056/NEJMoa054409.
145. Puett RC, Schwartz J, Hart JE, Yanosky JD, Speizer FE, Suh H, Paciorek CJ, Neas LM, Laden F. Chronic particulate exposure, mortality, and coronary heart disease in the nurses' health study. Am J Epidemiol. 2008;168:1161-1168. doi: 10.1093/aje/kwn232.
146. Hart JE, Chiuve SE, Laden F, Albert CM. Roadway proximity and risk of sudden cardiac death in women. Circulation. 2014;130:1474-1482. doi: 10.1161/CIRCULATIONAHA.114.011489.
147. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J. 1987;113:799-804.
148. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581-2588. doi: 10.1056/ NEJMoa043938.
149. Adabag AS, Therneau TM, Gersh BJ, Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA. 2008;300:2022-2029. doi: 10.1001/jama.2008.553.
150. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, Myerburg RJ. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003;42:652-658.
151. ADELSON L, HOFFMAN W. Sudden death from coronary disease related to a lethal mechanism arising independently of vascular occlusion or myocardial damage. JAMA. 1961;176:129-135.
152. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92:1701-1709.
153. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137-1140. doi: 10.1056/NEJM198405033101801.
154. Kramer MC, Rittersma SZ, de Winter RJ, Ladich ER, Fowler DR, Liang YH, Kutys R, Carter-Monroe N, Kolodgie FD, van der Wal AC, Virmani R. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol. 2010;55:122-132. doi: 10.1016/j.jacc.2009.09.007.
155. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282. doi: 10.1056/NEJM199705013361802.
156. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97:2110-2116.
157. Pouleur AC, Barkoudah E, Uno H, et al; VALIANT Investigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010;122:597-602. doi: 10.1161/ CIRCULATIONAHA.110.940619.
158. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 1993;88:2953-2961.
159. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250-258.
160. Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Perkiömäki JS, Schmidt G, Huikuri HV. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006;97:480-484. doi: 10.1016/j.amjcard.2005.09.077.
161. Buxton AE. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm. 2009;6:836-847. doi: 10.1016/j. hrthm.2009.02.016.
162. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML; MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004;43:1459-1465. doi: 10.1016/j.jacc.2003.11.038.
163. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. doi: 10.1056/ NEJMoa013474.
164. Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter- defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120:2170-2176. doi: 10.1161/ CIRCULATIONAHA.109.853689.
165. Epstein AE, DiMarco JP, Ellenbogen KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-e408. doi: 10.1161/ CIRCUALTIONAHA.108.189742.
166. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488. doi: 10.1056/NEJMoa041489.
167. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J; IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427-1436. doi: 10.1056/ NEJMoa0901889.
168. Buxton AE. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter- defibrillator. Circulation. 2005;111:2537-49; discussion 2537. doi: 10.1161/01.CIR.0000165057.88551.2C.
169. Cheng A, Zhang Y, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observatoinal Study of Implantable Cardioverter Defibrillators (PROSE-ICD). Circ Arrhythm Electrophysiol. 2014;7:1084-1091.
170. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-1166. doi: 10.1016/j. jacc.2005.11.045.
171. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890. doi: 10.1056/ NEJM199912163412503.
172. Lee DC, Goldberger JJ. CMR for sudden cardiac death risk stratification: are we there yet? JACC Cardiovasc Imaging. 2013;6:345-348. doi: 10.1016/j.jcmg.2012.12.006.
173. Exner DV, Kavanagh KM, Slawnych MP, et al; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007;50:2275-2284. doi: 10.1016/j. jacc.2007.08.042.
174. Zaman S, Narayan A, Thiagalingam A, Sivagangabalan G, Thomas S, Ross DL, Kovoor P. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction. Circulation. 2014;129:848-854. doi: 10.1161/CIRCULATIONAHA.113.005146.
175. Zile MR, Gaasch WH, Anand IS, et al; I-Preserve Investigators. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010;121:1393-1405. doi: 10.1161/CIRCULATIONAHA.109.909614.
176. Chan MM, Lam CS. How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail. 2013;15:604-613. doi: 10.1093/ eurjhf/hft062.
177. Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeffer MA. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004;110:2180-2183. doi: 10.1161/01.CIR.0000144474.65922.AA.
178. Al-Khatib SM, Shaw LK, O'Connor C, Kong M, Califf RM. Incidence and predictors of sudden cardiac death in patients with diastolic heart failure. J Cardiovasc Electrophysiol. 2007;18:1231-1235. doi: 10.1111/j.1540-8167.2007.00957.x.
179. Adabag S, Rector TS, Anand IS, McMurray JJ, Zile M, Komajda M, McKelvie RS, Massie B, Carson PE. A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2014;16:1175-1182. doi: 10.1002/ejhf.172.
180. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001;50:399-408.
181. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm. 2005;2:1277-1282. doi: 10.1016/j. hrthm.2005.09.008.
182. Ikeda T, Yusu S, Nakamura K, Yoshino H. Risk stratification for sudden cardiac death. Circ J. 2007;71(Suppl A):A106-A114.
183. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-1816. doi: 10.1161/ CIRCULATIONAHA.106.174287.
184. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270-276. doi: 10.1093/eurheartj/ehm342.
185. Lakdawala NK, Winterfield JR, Funke BH. Dilated cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6:228-237. doi: 10.1161/ CIRCEP.111.962050.
186. Epstein AE, DiMarco JP, Ellenbogen KA, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352. doi: 10.1161/ CIR.0b013e318276ce9b.
187. Bardy GH, Lee KL, Mark DB, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. doi: 10.1056/NEJMoa043399.
188. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158. doi: 10.1056/NEJMoa033088.
189. Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace. 2010;12:1564-1570. doi: 10.1093/europace/euq329.
190. Goldberger JJ, Subačius H, Patel T, Cunnane R, Kadish AH. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2014;63:1879-1889. doi: 10.1016/j. jacc.2013.12.021.
191. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896-908. doi: 10.1001/ jama.2013.1363.
192. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64:83-99. doi: 10.1016/j.jacc.2014.05.003.
193. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733-2779.
194. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761-2796. doi: 10.1161/CIR.0b013e318223e230.
195. O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35:2010-2020. doi: 10.1093/eurheartj/eht439.
196. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533-1541. doi: 10.1161/ CIRCULATIONAHA.108.840827.
197. Murray B. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature. J Genet Couns. 2012;21:494-504. doi: 10.1007/s10897-012-9497-7.
198. den Haan AD, Tan BY, Zikusoka MN, Lladó LI, Jain R, Daly A, Tichnell C, James C, Amat-Alarcon N, Abraham T, Russell SD, Bluemke DA, Calkins H, Dalal D, Judge DP. Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circ Cardiovasc Genet. 2009;2:428-435. doi: 10.1161/CIRCGENETICS.109.858217.
199. Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation. 2003;108:3000-3005. doi: 10.1161/01. CIR.0000108396.65446.21.
200. Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P, Ward D, Sen-Chowdhry S, Elliott PM, McKenna WJ. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123:2701-2709. doi: 10.1161/CIRCULATIONAHA.110.976936.
201. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084-3091. doi: 10.1161/01.CIR.0000103130.33451.D2.
202. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation. 2004;110:1879-1884. doi: 10.1161/01. CIR.0000143375.93288.82.
203. Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart. 2005;91:1167-1172. doi: 10.1136/hrt.2004.038620.
204. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol. 2011;58:1485-1496. doi: 10.1016/j.jacc.2011.06.043.
205. Loire R, Tabib A. [Unexpected sudden cardiac death. An evaluation of 1000 autopsies]. Arch Mal Coeur Vaiss. 1996;89:13-18.
206. Groves P. Valve disease: Surgery of valve disease: late results and late complications. Heart. 2001;86:715-721.
207. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290-3295. doi: 10.1161/ CIRCULATIONAHA.104.495903.
208. Bhattacharyya S, Hayward C, Pepper J, Senior R. Risk stratification in asymptomatic severe aortic stenosis: a critical appraisal. Eur Heart J. 2012;33:2377-2387. doi: 10.1093/eurheartj/ehs190.
209. Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM, Choo SJ, Park SW, Song JK, Lee JW, Park PW. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation. 2010;121:1502-1509. doi: 10.1161/CIRCULATIONAHA.109.909903.
210. Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507-518. doi: 10.1016/S0140-6736(05)17869-6.
211. Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F, Cannon BC, Asirvatham SJ, Ackerman MJ. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62:222-230. doi: 10.1016/j.jacc.2013.02.060.
212. Wever EF, Robles de Medina EO. Sudden death in patients without structural heart disease. J Am Coll Cardiol. 2004;43:1137-1144. doi: 10.1016/j.jacc.2003.10.053.
213. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008;29:1670-1680. doi: 10.1093/ eurheartj/ehn219.
214. Papadakis M, Raju H, Behr ER, De Noronha SV, Spath N, Kouloubinis A, Sheppard MN, Sharma S. Sudden cardiac death with autopsy findings of uncertain significance: potential for erroneous interpretation. Circ Arrhythm Electrophysiol. 2013;6:588-596. doi: 10.1161/ CIRCEP.113.000111.
215. Hofman N, Tan HL, Alders M, Kolder I, de Haij S, Mannens MM, Lombardi MP, Dit Deprez RH, van Langen I, Wilde AA. Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience. Circulation. 2013;128:1513-1521. doi: 10.1161/ CIRCULATIONAHA.112.000091.
216. Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J. 1975;89:378-390.
217. Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124:2181-2184. doi: 10.1161/CIRCULATIONAHA.111.062182.
218. Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol. 2008;51:2291-2300. doi: 10.1016/j.jacc.2008.02.068.
219. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866-1874. doi: 10.1056/NEJMoa022147.
220. Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004;1:276-283. doi: 10.1016/j. hrthm.2004.04.021.
221. Shimizu W, Noda T, Takaki H, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol. 2003;41:633-642.
222. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761-1767. doi: 10.1161/CIRCULATIONAHA.109.863209.
223. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95.
224. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960-965. doi: 10.1056/NEJM199810013391404.
225. Moss AJ, Shimizu W, Wilde AA, et al. Clinical aspects of type-1 long- QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007;115:2481-2489. doi: 10.1161/CIRCULATIONAHA.106.665406.
226. Shimizu W, Moss AJ, Wilde AA, et al. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol. 2009;54:2052-2062. doi: 10.1016/j.jacc.2009.08.028.
227. Shimizu W, Horie M, Ohno S, et al. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol. 2004;44:117-125. doi: 10.1016/j.jacc.2004.03.043.
228. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932-1963. doi: 10.1016/j. hrthm.2013.05.014.
229. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391-1396.
230. Gaw AC, Lee B, Gervacio-Domingo G, Antzelevitch C, Divinagracia R, Jocano F Jr. Unraveling the Enigma of Bangungut: Is Sudden Unexplained Nocturnal Death Syndrome (SUNDS) in the Philippines a Disease Allelic to the Brugada Syndrome? Philipp J Intern Med. 2011;49:165-176.
231. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA; Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514-2519.
232. Shimizu W, Matsuo K, Kokubo Y, Satomi K, Kurita T, Noda T, Nagaya N, Suyama K, Aihara N, Kamakura S, Inamoto N, Akahoshi M, Tomoike H. Sex hormone and gender difference-role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol. 2007;18:415-421. doi: 10.1111/j.1540-8167.2006.00743.x.
233. Sakabe M, Fujiki A, Tani M, Nishida K, Mizumaki K, Inoue H. Proportion and prognosis of healthy people with coved or saddle-back type ST segment elevation in the right precordial leads during 10 years follow-up. Eur Heart J. 2003;24:1488-1493.
234. Tsuji H, Sato T, Morisaki K, Iwasaka T. Prognosis of subjects with Brugada-type electrocardiogram in a population of middle-aged Japanese diagnosed during a health examination. Am J Cardiol. 2008;102:584-587. doi: 10.1016/j.amjcard.2008.04.066.
235. Gervacio-Domingo G, Isidro J, Tirona J, Gabriel E, David G, Amarillo ML, Morales D, Dans A. The Brugada type 1 electrocardiographic pattern is common among Filipinos. J Clin Epidemiol. 2008;61:1067-1072. doi: 10.1016/j.jclinepi.2007.11.009.
236. Ito H, Yano K, Chen R, He Q, Curb JD. The prevalence and prognosis of a Brugada-type electrocardiogram in a population of middle-aged Japanese-American men with follow-up of three decades. Am J Med Sci. 2006;331:25-29.
237. Letsas KP, Gavrielatos G, Efremidis M, Kounas SP, Filippatos GS, Sideris A, Kardaras F. Prevalence of Brugada sign in a Greek tertiary hospital population. Europace. 2007;9:1077-1080. doi: 10.1093/europace/ eum221.
238. Gallagher MM, Forleo GB, Behr ER, Magliano G, De Luca L, Morgia V, De Liberato F, Romeo F. Prevalence and significance of Brugada-type ECG in 12, 012 apparently healthy European subjects. Int J Cardiol. 2008;130:44-48. doi: 10.1016/j.ijcard.2007.07.159.
239. Pecini R, Cedergreen P, Theilade S, Haunsø S, Theilade J, Jensen GB. The prevalence and relevance of the Brugada-type electrocardiogram in the Danish general population: data from the Copenhagen City Heart Study. Europace. 2010;12:982-986. doi: 10.1093/europace/euq077.
240. Patel SS, Anees S, Anees SS, Ferrick KJ. Prevalence of a Brugada pattern electrocardiogram in an urban population in the United States. Pacing Clin Electrophysiol. 2009;32:704-708. doi: 10.1111/j.1540-8159.2009.02354.x.
241. Lee C, Soni A, Tate RB, Cuddy TE. The incidence and prognosis of Brugada electrocardiographic pattern in the Manitoba Follow-Up Study. Can J Cardiol. 2005;21:1286-1290.
242. Kamakura S, Ohe T, Nakazawa K, et al; Brugada Syndrome Investigators in Japan. Long-term prognosis of probands with Brugada-pattern STelevation in leads V1-V3. Circ Arrhythm Electrophysiol. 2009;2:495-503. doi: 10.1161/CIRCEP.108.816892.
243. Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation. 2010;121:635-643. doi: 10.1161/ CIRCULATIONAHA.109.887026.
244. Delise P, Allocca G, Marras E, Giustetto C, Gaita F, Sciarra L, Calo L, Proclemer A, Marziali M, Rebellato L, Berton G, Coro L, Sitta N. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J. 2011;32:169-176. doi: 10.1093/ eurheartj/ehq381.
245. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512-1519.
246. Hayashi M, Denjoy I, Hayashi M, Extramiana F, Maltret A, Roux- Buisson N, Lupoglazoff JM, Klug D, Maury P, Messali A, Guicheney P, Leenhardt A. The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands. Europace. 2012;14:1344-1351. doi: 10.1093/europace/eus031.
247. Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009;119:2426-2434. doi: 10.1161/ CIRCULATIONAHA.108.829267.
248. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74.
249. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart. 2003;89:66-70.
250. Swan H, Piippo K, Viitasalo M, Heikkilä P, Paavonen T, Kainulainen K, Kere J, Keto P, Kontula K, Toivonen L. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol. 1999;34:2035-2042.
251. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AA, Knollmann BC. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009;15:380-383. doi: 10.1038/nm.1942.
252. FENICHEL NN. A long term study of concave RS-T elevation-a normal variant of the electrocardiogram. Angiology. 1962;13:360-366.
253. Klatsky AL, Oehm R, Cooper RA, Udaltsova N, Armstrong MA. The early repolarization normal variant electrocardiogram: correlates and consequences. Am J Med. 2003;115:171-177.
254. Haïssaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008;358:2016-2023. doi: 10.1056/NEJMoa071968.
255. Rosso R, Kogan E, Belhassen B, Rozovski U, Scheinman MM, Zeltser D, Halkin A, Steinvil A, Heller K, Glikson M, Katz A, Viskin S. J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol. 2008;52:1231-1238. doi: 10.1016/j.jacc.2008.07.010.
256. Tikkanen JT, Anttonen O, Junttila MJ, Aro AL, Kerola T, Rissanen HA, Reunanen A, Huikuri HV. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med. 2009;361:2529-2537. doi: 10.1056/NEJMoa0907589.
257. Sinner MF, Reinhard W, Müller M, et al. Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med. 2010;7:e1000314. doi: 10.1371/journal.pmed.1000314.
258. Olson KA, Viera AJ, Soliman EZ, Crow RS, Rosamond WD. Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. Eur Heart J. 2011;32:3098-3106. doi: 10.1093/eurheartj/ehr264.
259. Ilkhanoff L, Soliman EZ, Prineas RJ, Walsh JA 3rd, Ning H, Liu K, Carr JJ, Jacobs DR Jr, Lloyd-Jones DM. Clinical characteristics and outcomes associated with the natural history of early repolarization in a young, biracial cohort followed to middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circ Arrhythm Electrophysiol. 2014;7:392-399. doi: 10.1161/CIRCEP.113.000874.
260. Haruta D, Matsuo K, Tsuneto A, Ichimaru S, Hida A, Sera N, Imaizumi M, Nakashima E, Maemura K, Akahoshi M. Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram. Circulation. 2011;123:2931-2937. doi: 10.1161/ CIRCULATIONAHA.110.006460.
261. Hisamatsu T, Ohkubo T, Miura K, Yamamoto T, Fujiyoshi A, Miyagawa N, Kadota A, Takashima N, Nagasawa SY, Kita Y, Murakami Y, Okayama A, Horie M, Okamura T, Ueshima H; NIPPON DATA90 Research Group. Association between J-point elevation and death from coronary artery disease-15-year follow up of the NIPPON DATA90. Circ J. 2013;77:1260-1266.
262. Noseworthy PA, Tikkanen JT, Porthan K, Oikarinen L, Pietilä A, Harald K, Peloso GM, Merchant FM, Jula A, Väänänen H, Hwang SJ, O'Donnell CJ, Salomaa V, Newton-Cheh C, Huikuri HV. The early repolarization pattern in the general population: clinical correlates and heritability. J Am Coll Cardiol. 2011;57:2284-2289. doi: 10.1016/j.jacc.2011.04.003.
263. Tikkanen JT, Junttila MJ, Anttonen O, Aro AL, Luttinen S, Kerola T, Sager SJ, Rissanen HA, Myerburg RJ, Reunanen A, Huikuri HV. Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome. Circulation. 2011;123:2666-2673. doi: 10.1161/CIRCULATIONAHA.110.014068.
264. Junttila MJ, Raatikainen MJP, Karjalainen J, Kauma H, Kesaniemi YA, Huikuri HV. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J. 2004;25:874-878.
265. Sinner MF, Pfeufer A, Perz S, Schulze-Bahr E, Monnig G, Eckardt L, Beckmann BM, Wichmann HE, Breithardt G, Steinbeck G, Fabritz L, Kaab S, Kirchhof P. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study. Europace. 2009;11:1338-1344.
266. Yamakawa Y, Ishikawa T, Uchino K, Mochida Y, Ebina T, Sumita S, Kobayashi T, Matsushita K, Matsumoto K, Ohkusu Y, Nishizawa T, Takigiku K, Iwamoto M, Kimura K, Umemura S. Prevalence of right bundle- branch block and right precordial ST-segment elevation (Brugada-type electrocardiogram) in Japanese children. Circ J. 2004;68:275-279.
267. Oe H, Takagi M, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T, Yoshiyama M, Nishimoto M, Tanaka K, Yoshikawa J. Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population. Pacing Clin Electrophysiol. 2005;28:549-554.
268. Rollin A, Maury P, Bongard V, Sacher F, Delay M, Duparc A, Mondoly P, Carrié D, Ferrières J, Ruidavets JB. Prevalence, prognosis, and identification of the malignant form of early repolarization pattern in a populationbased study. Am J Cardiol. 2012;110:1302-1308.
269. Uberoi A, MD, Jain NA, Perez M, Weinkopff A, Ashley E, Hadley D, Turakhia MP, Froelicher V. Early repolarization in an ambulatory clinical population. Circulation. 2011;124:2208-2214.